Melio F R, Mallon W K, Newton E
Department of Emergency Medicine, University of Southern California School of Medicine, Los Angeles.
Ann Emerg Med. 1993 Apr;22(4):709-13. doi: 10.1016/s0196-0644(05)81853-0.
To evaluate the efficacy of adenosine in the treatment of emergency department patients with unstable paroxysmal supraventricular tachycardia (PSVT).
A retrospective chart review conducted over two years.
A university-affiliated hospital ED.
Patients with unstable PSVT (systolic blood pressure of less than 90 mm Hg, chest pain, pulmonary edema, and/or altered mental status) who were treated with adenosine.
Patients' preadenosine and postadenosine heart rates, symptoms, and blood pressure were recorded, as were complications and recurrence of PSVT. PSVT was diagnosed by surface ECG.
Twelve patients were identified (three men and nine women with a mean age of 47.6 years). Nine patients presented with hypotension (mean systolic blood pressure, 79 mm Hg), ten with chest pain, and six with both chest pain and hypotension. There were no patients with altered mental status or pulmonary edema. Eight patients converted to sinus rhythm with a single 6-mg bolus of adenosine; the remaining four required an additional 12-mg bolus. In all cases, chest pain and hypotension resolved within minutes of conversion to sinus rhythm. There were no clinically significant adverse effects or recurrence of PSVT during ED observation (mean, 1.8 hours). All patients responded to adenosine; none required electrical cardioversion.
In the unstable patient with PSVT, adenosine appears to be a safe and effective alternative to current advanced cardiac life support-recommended immediate electrical cardioversion.
评估腺苷治疗急诊科不稳定阵发性室上性心动过速(PSVT)患者的疗效。
一项为期两年的回顾性病历审查。
一家大学附属医院急诊科。
接受腺苷治疗的不稳定PSVT患者(收缩压低于90 mmHg、胸痛、肺水肿和/或精神状态改变)。
记录患者使用腺苷前后的心率、症状和血压,以及PSVT的并发症和复发情况。PSVT通过体表心电图诊断。
共纳入12例患者(3例男性和9例女性,平均年龄47.6岁)。9例患者出现低血压(平均收缩压79 mmHg),10例有胸痛,6例既有胸痛又有低血压。没有精神状态改变或肺水肿的患者。8例患者单次静脉注射6 mg腺苷后转为窦性心律;其余4例需要额外静脉注射12 mg腺苷。在所有病例中,转为窦性心律后数分钟内胸痛和低血压均得到缓解。在急诊科观察期间(平均1.8小时),没有出现具有临床意义的不良反应或PSVT复发。所有患者对腺苷均有反应;无人需要电复律。
对于不稳定的PSVT患者,腺苷似乎是当前高级心脏生命支持推荐的立即电复律的一种安全有效的替代方法。